Fischer Medical Ventures Limited (NSE:FISCHER)
India · Delayed Price · Currency is INR 97.20
-9.87 (-9.22%)
Nov 4, 2025, 1:07 PM IST
Fischer Medical Ventures Revenue
Fischer Medical Ventures had revenue of 863.05M INR in the quarter ending September 30, 2025, with 117.64% growth. This brings the company's revenue in the last twelve months to 1.71B, up 141.85% year-over-year. In the fiscal year ending March 31, 2025, Fischer Medical Ventures had annual revenue of 1.11B with 427.61% growth.
Revenue (ttm)
1.71B
Revenue Growth
+141.85%
P/S Ratio
40.73
Revenue / Employee
42.67M
Employees
40
Market Cap
69.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.11B | 897.17M | 427.61% |
| Mar 31, 2024 | 209.81M | 208.02M | 11,588.75% |
| Mar 31, 2023 | 1.80M | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | 1.65M | -189.00K | -10.28% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 537.77B |
| Aurobindo Pharma | 320.25B |
| Cipla | 279.66B |
| Zydus Lifesciences | 236.08B |
| Apollo Hospitals Enterprise | 225.51B |
| Glenmark Pharmaceuticals | 134.56B |
| Alkem Laboratories | 133.04B |
| Mankind Pharma | 129.10B |
Fischer Medical Ventures News
- 3 months ago - Fischer Medical Ventures launches Chennai’s first high-resolution open MRI at Sunray Scans - Business Upturn